The Spin Off MI can maximizes shareholder holder value and sustains it, it also allows firms like VRX to package assets if they are serious about asset sales. I can see a BL trading in this market at $15 billion by itself.
I'm thinking the SPIN off news will be announced either this earnings meeting or next. BL
So BL goes to market and get its own 15 billion market cap and Salix gets it own $10 billion, and VRX with all pattens and co drug agreements get the rest. The spin-off also allows VRX to re-do some of its distribution of two of it most popular products. The Spin off will bring instant 150% market value to VRX for sustained period.
Only a week away.. Shorts covering at 100% premium yeap I see it..
It's easy at Walgreens..
FDA will be the catalyst, coupled with Walgreen's Rite Aid news
BL sales will blow the roof off of analyst expectations. Which will only get better...So its not a sell the news story its buy the news, buy the lows as we move to $90+
Walgreens CEO also said they like PAPA and will work with VRX to get the kinks out of a the new Distribution Deal.. Also Walgreens will add 2,000 Rite Aid stores to the network and operate under Rite Aid name. That's 11,000 retail locations VRX has to sell its products. I think we will see instant results on the Q2 VRX Walgreen numbers that will blow your mind and most analysts..
Ditto the debt.. $30 to $31 billion debt known in August 2015.. $1.00 drop in EPS,, Hardly... But The Street and Manipulation: Using mass media: Well that I can believe: Proprietary trading and investing requires anticipating events and exploiting them. Economic and financial analysis and quantitative tools help to identify opportunities, giving this strategy the sheen of sophisticated science. "But in fact, few manage to succeed at it consistently over long periods" The long period has just started!.
Which on a 40 cent rise day is less then a 8 million investment , nothing..This will hit $40 fast
Shorts much much pain as we move to $150
Its why Jim Cramers Charitable Fund is like 20% down this year. Hes always wrong.
How many weak nillies had already sold.. It takes very little money to buy up to $30 to $40 range. Maybe as little as $100 million, which is noting.. for a firm with 10 billion cash flow a year.
That is a $90 easy, cash flow is huge. Just need to control the cash flow out.
Again all based on Papa watching expenses and bringing 130 billion is sales in over 10 years. Then we should have $50 billion after debt for us..
Just don't know how much cash Papa set aside to make the next quarter his first full quarter rock.. B&L sales are very hot. Thin Contacts and plenty of drops in hot dry weather.
I would say we will see $25.00 on just that day alone..
Walgreens Boots Alliance CEO Stefano Pessina said he is “very confident” that the Rite Aid “deal will go through.” as per Forbes Today..
Only July 19th expect a green light from the FDA.. like 100% vs 1% that does not get approval. Smart VRX sells the old stuff to Europe for 1 billion in milestones and ramps up the new injection in the U.S. with sales to exceed $2 billion in the U.S. by end of 2017.. With all these billions coming the streets worry about VRX being able to fund 1.6 billion in debt by 2018 is a bunch of HOG Wash. The street should be thrown in Jail and Jim Cramer should be forced to pay every dollar back people lost listening to that crack pot and his January Fibonacci bull carp..
On January 25, 2016, Valeant announced that the FDA had accepted for review the Biologics License Application (BLA) submitted by AstraZeneca (LSE/SSE/NYSE: AZN) in partnership with Valeant for brodalumab injection, 210 mg, a monoclonal antibody that targets the IL-17 receptor, in development for patients with moderate to severe plaque psoriasis. The FDA assigned a Prescription Drug User Fee Act (PDUFA) action date of November 16, 2016.
Just watch...and learn.